Search BRITE hierarchies
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DA Xanthines
R03DA04 Theophylline [DG:DG01061]
D00371 Theophylline (JP18) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Phosphodiesterase Inhibitors, Airways Disease
Theophylline [DG:DG01061]
D00371 Theophylline (JP18)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
225 Bronchodilators
2251 Xanthines
D00371 Theophylline (JP18)
Classification of Japanese OTC drugs [BR:br08313]
Agents for respiratory organs
26 Antitussives and expectorants
D00371 Theophylline (JP18)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Theophylline
D00371 Theophylline (JP18)
Drug groups [BR:br08330]
Respiratory system agent
DG01616 Xanthine derivative
DG01609 Xanthine-type bronchodilator
DG01061 Theophylline
D00371 Theophylline
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG01061 Theophylline
D00371 Theophylline
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adenosine
ADORA1 [HSA:134] [KO:K04265]
D00371 Theophylline (JP18) <JP/US>
ADORA2B [HSA:136] [KO:K04267]
D00371 Theophylline (JP18) <JP/US>
Enzymes
Hydrolases (EC3)
Phosphodiesterases [EC:3.1.4.-]
PDE [HSA:10846 27115 50940 5136 5137 5138 5139 5140 5141 5142 5143 5144 5150 5151 5153 8622] [KO:K18438 K18436 K13298 K13755 K18283 K19021 K13296 K13293 K18437]
D00371 Theophylline (JP18) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00371 Theophylline
Drug metabolizing enzymes and transporters [br08309.html]
D00371
[ BRITE | KEGG2 | KEGG ]